Ling Yi
Overview
Explore the profile of Ling Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Li C, Bundschuh J, Gao X, Gong X, Li H, et al.
Environ Pollut
. 2025 Mar;
372:126026.
PMID: 40058558
Microplastics (MPs) are emerging environmental pollutants which represent a serious threat to ecosystems and human health and have received significant attention from the global community. Currently, a growing number of...
2.
Ma S, Yi L, Bian Y, Lv B, Zhang C, Li C, et al.
Cancer Chemother Pharmacol
. 2024 Dec;
95(1):5.
PMID: 39673613
Purpose: The study aims to investigate the absorption, metabolism, and excretion of donafenib, a deuterated derivative of sorafenib, in healthy Chinese male volunteers. Methods: Six healthy Chinese male volunteers were...
3.
Bai Z, Cheng X, Ma T, Li G, Wang X, Wang Z, et al.
Lung Cancer
. 2024 Oct;
197:107991.
PMID: 39454350
Purpose: Neoadjuvant chemoimmunotherapy has the potential to reduce tumor burden, improve the pathological complete response (pCR) rate, and significantly prolong patients' disease-free survival (DFS). However, the treatment's effectiveness varies among...
4.
Wang H, Yi L, Liu J, Mao T, Liu W
Cureus
. 2024 Sep;
16(8):e66436.
PMID: 39247017
Objective: This study aimed to explore the effect of 25-hydroxyvitamin D (25(OH)D) levels in follicular fluid (FF) on the embryo outcome with diminished ovarian reserve (DOR) patients undergoing in vitro...
5.
Yang M, Yi L, Jia F, Zeng X, Liu Z
Clinics (Sao Paulo)
. 2024 Aug;
79:100475.
PMID: 39096859
Background: Influenza-Associated Encephalopathy/Encephalitis (IAE) is characterized by high incidence and poor prognosis. The aim of this study is to describe the clinical features and outcomes of IAE in pediatric patients....
6.
Gao X, Yi L, Fu S, Lu Z, Wang J, Zhang S
J Surg Res
. 2024 Jul;
301:231-239.
PMID: 38968924
Introduction: Curative lung resection remains the key therapeutic strategy for early-stage non-small cell lung cancer (NSCLC). However, a proportion of patients still experience variable outcomes and eventually develop recurrence or...
7.
Yi L, Yan J, Wei P, Long S, Wang X, Gu M, et al.
Eur J Immunol
. 2024 Jun;
54(8):e2350796.
PMID: 38922884
Tuberculosis (TB) was the leading cause of death from a single infectious agent before the coronavirus pandemic. Therefore, it is important to search for severity biomarkers and devise appropriate therapies....
8.
Jiang Y, Gao X, Yang X, Gong P, Pan Z, Yi L, et al.
Sci Total Environ
. 2024 Apr;
929:172572.
PMID: 38641113
Carbonate bound arsenic act as an important reservoir for arsenic (As) in nature aquifers. Sulfate-reducing bacteria (SRB), one of the dominant bacterial species in reductive groundwater, profoundly affects the biogeochemical...
9.
Yi L, Xu Z, Ma T, Wang C, Wei P, Xiao B, et al.
Cancer Immunol Immunother
. 2024 Apr;
73(6):99.
PMID: 38619623
Purpose: Neoadjuvant PD-1 blockade combined with chemotherapy is a promising treatment for resectable non-small cell lung cancer (NSCLC), yet the immunological mechanisms contributing to tumor regression and biomarkers corresponding to...
10.
Yan Z, Ma T, Wang X, Yi L, Wei P, Zhang H, et al.
Heliyon
. 2024 Apr;
10(7):e28126.
PMID: 38560237
The T cell immunoglobulin and mucin-domain containing-3 (TIM-3) receptor has gained significant attention as a promising target for cancer immunotherapy. The inhibitory effect of T cells by TIM-3 is mediated...